Roberto Garcia de Varona, APRN
Family · Miami Lakes, FLNPI 1578183521
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations.
Across 26 payments — averaging $21.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$97
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$60
- Hologic Sales And Service, LLC$55
- Kowa Pharmaceuticals America, Inc.$54
- GSK$46
- Pfizer$46
- plus $200 from 7 others
What the payments were for
- Food & beverage$558100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 5 | $97 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $60 |
| Hologic Sales And Service, LLC | 2 | $55 |
| Kowa Pharmaceuticals America, Inc. | 3 | $54 |
| GSK | 2 | $46 |
| Pfizer | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Shield Therapeutics Inc | 1 | $41 |
| Amgen | 2 | $32 |
| Optinose US, Inc. | 1 | $24 |
| IBSA Pharma Inc. | 1 | $22 |
| Abbott | 1 | $22 |
| Exact Sciences | 1 | $18 |
How this compares
$558 in reported general payments places this provider in the 55th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 15 | $770 |
| Omeprazole | 66 | $709 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $526 |
| Metoprolol Succinate | 41 | $509 |
| Levothyroxine Sodium | 35 | $416 |
| Diclofenac Sodium | 46 | $409 |
| Atorvastatin Calcium | 55 | $368 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $330 |
| Losartan Potassium | 34 | $284 |
| Rosuvastatin Calcium | 20 | $274 |
| Lisinopril | 56 | $248 |
| Famotidine | 19 | $220 |
| Gabapentin | 37 | $215 |
| Fluticasone Propionate | 18 | $191 |
| Amlodipine Besylate | 46 | $145 |
Paid to pharmacies, not to this prescriber.
Other family in Miami Lakes
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.